Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax

Testing Plasmodium vivax antimicrobial sensitivity is limited to ex vivo schizont maturation assays, which preclude determining the IC50s of delayed action antimalarials such as doxycycline. Using Plasmodium cynomolgi as a model for P. vivax, we determined the physiologically significant delayed death effect induced by doxycycline [IC50(96 h), 1,401 ± 607 nM]. As expected, IC50(96 h) to chloroquine (20.4 nM), piperaquine (12.6 µM), and tafenoquine (1,424 nM) were not affected by extended exposure.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

Antimicrobial agents and chemotherapy - (2024) vom: 08. Apr., Seite e0028024

Sprache:

Englisch

Beteiligte Personen:

Christensen, Peter [VerfasserIn]
Cinzah, Rosy [VerfasserIn]
Suwanarusk, Rossarin [VerfasserIn]
Chua, Adeline Chiew Yen [VerfasserIn]
Kaneko, Osamu [VerfasserIn]
Kyle, Dennis E [VerfasserIn]
Aung, Htin Lin [VerfasserIn]
Matheson, Jessica [VerfasserIn]
Bifani, Pablo [VerfasserIn]
Rénia, Laurent [VerfasserIn]
Cook, Gregory M [VerfasserIn]
Snounou, Georges [VerfasserIn]
Russell, Bruce [VerfasserIn]

Links:

Volltext

Themen:

Antimalarial agents
Chloroquine
Doxycycline
Journal Article
Plasmodium cynomolgi
Plasmodium vivax
Tafenoquine

Anmerkungen:

Date Revised 08.04.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1128/aac.00280-24

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370768094